First reported human Castellaniella defragrans bacteraemia: a case report.

Swiss Med WklySep 25, 2026 (epub)

Morgane Nédellec, Titouan Cerruti, Damien Jacot et al.

✦ AI-curated · Sources linked

Case in brief

An 82-year-old man with monoclonal B-cell lymphocytosis, later diagnosed with chronic lymphocytic leukaemia, presented with fever, confusion, and signs of sepsis. Blood cultures revealed sustained growth of Castellaniella defragrans for 7 days. Imaging showed pulmonary consolidations and mediastinal infiltration. The patient was treated with high-dose meropenem, leading to clearance of the bacteraemia and clinical improvement over five weeks.

What made this case unusual

This case is notable as it represents the first documented instance of Castellaniella defragrans causing bacteraemia in a human, highlighting its potential pathogenicity in immunocompromised individuals.

Diagnostic / clinical pearl

Clinicians should consider environmental microorganisms like Castellaniella defragrans as potential pathogens in immunocompromised patients presenting with sepsis.

Why it matters

This case underscores the importance of recognizing non-traditional pathogens in patients with weakened immune systems, which can lead to severe infections.

Source

Published in Swiss Med Wkly. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Infectious Diseases

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.